Product Information
MICARDIS HCT 40-12.5 MG TABLET is a brand product labeled by Boehringer Ingelheim Pharmaceuticals Inc., priced at $4.4836 per EA under NDC 00597004337. Its NADAC has been published 427 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the telmisartan and hydrochlorothiazide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
12.5; 40 mg/1; mg/1
Manufacturer
Boehringer Ingelheim Pharmaceuticals Inc.NDC
00597004337
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; TELMISARTANApproval Type
New Drug (NDA)
FDA Application
NDA021162On Market Since
12/1/2000
Pharmacological Classes
Price Statistics
The NADAC for MICARDIS HCT 40-12.5 MG TABLET has been published 427 times since Nov 28, 2013, and over the history we have for it it has risen 2.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.4836 per EA |
|---|---|
| All-time high | $7.1010 (Jan 15, 2020) |
| All-time low | $4.3245 (Dec 18, 2013) |
| 52-week high | $4.4995 |
| 52-week low | $4.4836 |
| Median price | $5.2229 |
| Average price | $5.5625 |
| Largest weekly change | -36.4% (May 22, 2024) |
| Weeks tracked | 427 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 92% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MICARDIS HCT 40-12.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MICARDIS HCT 40-12.5 MG TABLET, manufactured by Boehringer Ingelheim Pharmaceuticals Inc., is $4.4836 per EA (NDC 00597004337), effective Jun 24, 2026.
How has the price of MICARDIS HCT 40-12.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for MICARDIS HCT 40-12.5 MG TABLET has risen 2.2%. It has been tracked across 427 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MICARDIS HCT 40-12.5 MG TABLET?
Since Nov 28, 2013, the NADAC for MICARDIS HCT 40-12.5 MG TABLET has ranged from a low of $4.3245 (Dec 18, 2013) to a high of $7.1010 (Jan 15, 2020), with a median of $5.2229 per EA.
Are there cheaper alternatives to MICARDIS HCT 40-12.5 MG TABLET?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB, is $0.3713 per EA — about 92% below MICARDIS HCT 40-12.5 MG TABLET.
Who manufactures MICARDIS HCT 40-12.5 MG TABLET?
MICARDIS HCT 40-12.5 MG TABLET (NDC 00597004337) is labeled by Boehringer Ingelheim Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification